AADCX
Price
$16.62
Change
-$0.25 (-1.48%)
Updated
Nov 13 closing price
Net Assets
1.03B
PAAQX
Price
$15.37
Change
-$0.23 (-1.47%)
Updated
Nov 13 closing price
Net Assets
1.96B
Interact to see
Advertisement

AADCX vs PAAQX

Header iconAADCX vs PAAQX Comparison
Open Charts AADCX vs PAAQXBanner chart's image
Invesco Select Risk: Growth Investor C
Price$16.62
Change-$0.25 (-1.48%)
VolumeN/A
Net Assets1.03B
Invesco Active Allocation R6
Price$15.37
Change-$0.23 (-1.47%)
VolumeN/A
Net Assets1.96B
AADCX vs PAAQX Comparison Chart in %
View a ticker or compare two or three
VS
AADCX vs. PAAQX commentary
Nov 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AADCX is a Buy and PAAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAAQX has more cash in the bank: 1.97B vs. AADCX (1.03B). PAAQX pays higher dividends than AADCX: PAAQX (2.17) vs AADCX (0.91). AADCX was incepted earlier than PAAQX: AADCX (22 years) vs PAAQX (6 years). AADCX (1.71) is less costly to investors than PAAQX (0.67). PAAQX (43.00) and AADCX (42.00) have comparable annual turnover. AADCX has a lower initial minimum investment than PAAQX: AADCX (1000) vs PAAQX (1000000). AADCX (8.05) and PAAQX (7.73) have marching annual gain over last year. PAAQX return over 5 years is better than : 8.77 vs. AADCX (5.63).
AADCXPAAQXAADCX / PAAQX
Total Expense Ratio1.710.67255%
Annual Report Gross Expense Ratio1.710.67255%
Fund Existence22 years6 years-
Gain YTD12.44913.59992%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B1.97B53%
Annual Yield % from dividends0.912.1742%
Returns for 1 year8.057.73104%
Returns for 3 years26.4330.7386%
Returns for 5 years5.638.7764%
Returns for 10 years33.94N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCRB16.760.75
+4.72%
Seres Therapeutics Inc
MSC3.880.15
+4.16%
Studio City International Holdings Limited
HAE73.910.79
+1.08%
Haemonetics Corp
EME618.96-24.42
-3.80%
EMCOR Group
CMMB2.55-0.13
-4.85%
Chemomab Therapeutics Ltd